PR Newswire (press release) The system is still in development for the United States; it is not available for in vitro diagnostic use in the United States. Beckman Coulter, the stylized logo, and VERIS are trademarks of Beckman ... 更多 »
MarketWatch "We are very excited to have received FDA clearance," said Andrew Morris, CEO, SQI Diagnostics. "This clearance lays the foundation for sales in the US market of our newest in vitro diagnostic (IVD) ... 更多 »
CNNMoney Venaxis, Inc. is an in vitro diagnostic company focused on the clinical development and commercialization of its CE Marked APPY1 Test, the Company's rapid blood based test for appendicitis. T2 Biosystems to Present at the Canaccord Genuity Medical Technologies ... Stockhouse 此专题所有 21 篇报道 »
PR Newswire (press release) This report, Reimbursement for In Vitro Diagnostic (IVD) Tests examines the U.S. reimbursement system for IVD tests, focusing on key issues of current concern to industry. It covers only commercialized ... 更多 »
Newswire Today (press release) Despite economic and industry challenges, the global in vitro diagnostics (IVD) market is growing robustly at double the rate of the global pharmaceutical industry. The market will remain buoyant as the ... 更多 »
Lexology (registration) The Measures related to the Administration of Registration of In Vitro Diagnostic Reagents (“Measures”) issued on 30 July 2014 by the China Food and Drug Administration (“CFDA”) entered into force ...
MarketWatch Chinese in vitro diagnostic reagent market consists of biochemical diagnostic reagents, immunodiagnostic reagents and molecular diagnostic reagents. Among them, the immune reagents and ... 更多 »
pharmabiz.com Despite economic and industry challenges, the global in vitro diagnostics (IVD) market is growing robustly – at double the rate of the global pharmaceutical industry. The market will remain buoyant as ... Report: Radical New IVD Test Approaches Key To Growth SYS-CON Media (press release) 此专题所有 3 篇报道 »
